Clinical Trial Update: Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluating low-dose aspirin to prevent pre-eclampsia and intrauterine growth restriction in nulliparous women with abnormal first-tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrauterine Growth Restriction
• Pre-eclampsia

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University Hospital, Tours | Conditions: Pre-eclampsia, Intra-uterine Growth Restriction | Phase 4 | Status: COMPLETED